# Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries

> **NCT04669366** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1205 (actual)

## Conditions studied

- Kidney Neoplasms

## Interventions

- **DRUG:** sunitinib
- **DRUG:** axitinib

## Key facts

- **NCT ID:** NCT04669366
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-20
- **Primary completion:** 2021-07-31
- **Final completion:** 2022-03-18
- **Target enrollment:** 1205 (ACTUAL)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04669366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04669366, "Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04669366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*